BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kao JH. Appropriate use of interferon for treatment of chronic hepatitis B. Hepatol Res. 2007;37:S47-S54. [PMID: 17627636 DOI: 10.1111/j.1872-034x.2007.00105.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Song J, Zhou Y, Li S, Wang B, Zheng X, Wu J, Gibbert K, Dittmer U, Lu M, Yang D. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection. PLoS One 2014;9:e90977. [PMID: 24618716 DOI: 10.1371/journal.pone.0090977] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
2 Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int. 2007;1:415-430. [PMID: 19669337 DOI: 10.1007/s12072-007-9033-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
3 Zhu Y, Qin B, Xiao C, Lu X, Chen L. Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients. Dig Dis Sci 2012;57:2355-61. [PMID: 22585383 DOI: 10.1007/s10620-012-2169-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
4 Kao JH. Molecular epidemiology of hepatitis B virus. Korean J Intern Med 2011;26:255-61. [PMID: 22016585 DOI: 10.3904/kjim.2011.26.3.255] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]